Global licensing agreement formed for innovative protein therapeutics for inflammatory indications

Zai Lab and Crescendo Biologics have entered a worldwide licensing agreement for the development, commercialisation and manufacture of innovative protein therapeutics for inflammatory indications.

More From BioPortfolio on "Global licensing agreement formed for innovative protein therapeutics for inflammatory indications"